Email This Release
Genzyme’s LEMTRADA™ (alemtuzumab) Application for MS Accepted for Review by the FDA
*
marks required fields
Recipient Name:
*
Recipient Email:
Message:
*
Enter security words:
Terms of Use
|
© 2024 Business Wire